
Global Gliptin Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
Gliptin Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The Gliptin market is expected to grow from USD X.X million in 2021 to USD X.X million by 2027, at a CAGR of X.X% during the forecast period. The global Gliptin market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Gliptin market. The report focuses on well-known providers in the global Gliptin industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Gliptin Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Gliptin market covered in Chapter 4:
Eli Lilly
Merck & Co., Inc.
LGM Pharma
Boehringer Ingelheim Pharmaceuticals, Inc.
Novartis International AG
AstraZeneca
In Chapter 11 and 13.3, on the basis of types, the Gliptin market from 2016 to 2027 is primarily split into:
Sitagliptin (Januvia)
Vildagliptin (Galvus)
Saxagliptin (Onglyza)
Linagliptin (Tradjenta)
Alogliptin (Vipidia/Nesina)
Other Types
In Chapter 12 and 13.4, on the basis of applications, the Gliptin market from 2016 to 2027 covers:
Type 2 Diabetes
OtherDiseases
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2027) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2027
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Gliptin Market Share by Type (2021-2027)
1.5.2 Sitagliptin (Januvia)
1.5.3 Vildagliptin (Galvus)
1.5.4 Saxagliptin (Onglyza)
1.5.5 Linagliptin (Tradjenta)
1.5.6 Alogliptin (Vipidia/Nesina)
1.5.7 Other Types
1.6 Market by Application
1.6.1 Global Gliptin Market Share by Application (2021-2027)
1.6.2 Type 2 Diabetes
1.6.3 OtherDiseases
1.7 Gliptin Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Gliptin Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Gliptin Market
3.1 Value Chain Status
3.2 Gliptin Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Gliptin
3.2.3 Labor Cost of Gliptin
3.2.3.1 Labor Cost of Gliptin Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Eli Lilly
4.1.1 Eli Lilly Basic Information
4.1.2 Gliptin Product Profiles, Application and Specification
4.1.3 Eli Lilly Gliptin Market Performance (2016-2021)
4.1.4 Eli Lilly Business Overview
4.2 Merck & Co., Inc.
4.2.1 Merck & Co., Inc. Basic Information
4.2.2 Gliptin Product Profiles, Application and Specification
4.2.3 Merck & Co., Inc. Gliptin Market Performance (2016-2021)
4.2.4 Merck & Co., Inc. Business Overview
4.3 LGM Pharma
4.3.1 LGM Pharma Basic Information
4.3.2 Gliptin Product Profiles, Application and Specification
4.3.3 LGM Pharma Gliptin Market Performance (2016-2021)
4.3.4 LGM Pharma Business Overview
4.4 Boehringer Ingelheim Pharmaceuticals, Inc.
4.4.1 Boehringer Ingelheim Pharmaceuticals, Inc. Basic Information
4.4.2 Gliptin Product Profiles, Application and Specification
4.4.3 Boehringer Ingelheim Pharmaceuticals, Inc. Gliptin Market Performance (2016-2021)
4.4.4 Boehringer Ingelheim Pharmaceuticals, Inc. Business Overview
4.5 Novartis International AG
4.5.1 Novartis International AG Basic Information
4.5.2 Gliptin Product Profiles, Application and Specification
4.5.3 Novartis International AG Gliptin Market Performance (2016-2021)
4.5.4 Novartis International AG Business Overview
4.6 AstraZeneca
4.6.1 AstraZeneca Basic Information
4.6.2 Gliptin Product Profiles, Application and Specification
4.6.3 AstraZeneca Gliptin Market Performance (2016-2021)
4.6.4 AstraZeneca Business Overview
5 Global Gliptin Market Analysis by Regions
5.1 Global Gliptin Sales, Revenue and Market Share by Regions
5.1.1 Global Gliptin Sales by Regions (2016-2021)
5.1.2 Global Gliptin Revenue by Regions (2016-2021)
5.2 North America Gliptin Sales and Growth Rate (2016-2021)
5.3 Europe Gliptin Sales and Growth Rate (2016-2021)
5.4 Asia-Pacific Gliptin Sales and Growth Rate (2016-2021)
5.5 Middle East and Africa Gliptin Sales and Growth Rate (2016-2021)
5.6 South America Gliptin Sales and Growth Rate (2016-2021)
6 North America Gliptin Market Analysis by Countries
6.1 North America Gliptin Sales, Revenue and Market Share by Countries
6.1.1 North America Gliptin Sales by Countries (2016-2021)
6.1.2 North America Gliptin Revenue by Countries (2016-2021)
6.1.3 North America Gliptin Market Under COVID-19
6.2 United States Gliptin Sales and Growth Rate (2016-2021)
6.2.1 United States Gliptin Market Under COVID-19
6.3 Canada Gliptin Sales and Growth Rate (2016-2021)
6.4 Mexico Gliptin Sales and Growth Rate (2016-2021)
7 Europe Gliptin Market Analysis by Countries
7.1 Europe Gliptin Sales, Revenue and Market Share by Countries
7.1.1 Europe Gliptin Sales by Countries (2016-2021)
7.1.2 Europe Gliptin Revenue by Countries (2016-2021)
7.1.3 Europe Gliptin Market Under COVID-19
7.2 Germany Gliptin Sales and Growth Rate (2016-2021)
7.2.1 Germany Gliptin Market Under COVID-19
7.3 UK Gliptin Sales and Growth Rate (2016-2021)
7.3.1 UK Gliptin Market Under COVID-19
7.4 France Gliptin Sales and Growth Rate (2016-2021)
7.4.1 France Gliptin Market Under COVID-19
7.5 Italy Gliptin Sales and Growth Rate (2016-2021)
7.5.1 Italy Gliptin Market Under COVID-19
7.6 Spain Gliptin Sales and Growth Rate (2016-2021)
7.6.1 Spain Gliptin Market Under COVID-19
7.7 Russia Gliptin Sales and Growth Rate (2016-2021)
7.7.1 Russia Gliptin Market Under COVID-19
8 Asia-Pacific Gliptin Market Analysis by Countries
8.1 Asia-Pacific Gliptin Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Gliptin Sales by Countries (2016-2021)
8.1.2 Asia-Pacific Gliptin Revenue by Countries (2016-2021)
8.1.3 Asia-Pacific Gliptin Market Under COVID-19
8.2 China Gliptin Sales and Growth Rate (2016-2021)
8.2.1 China Gliptin Market Under COVID-19
8.3 Japan Gliptin Sales and Growth Rate (2016-2021)
8.3.1 Japan Gliptin Market Under COVID-19
8.4 South Korea Gliptin Sales and Growth Rate (2016-2021)
8.4.1 South Korea Gliptin Market Under COVID-19
8.5 Australia Gliptin Sales and Growth Rate (2016-2021)
8.6 India Gliptin Sales and Growth Rate (2016-2021)
8.6.1 India Gliptin Market Under COVID-19
8.7 Southeast Asia Gliptin Sales and Growth Rate (2016-2021)
8.7.1 Southeast Asia Gliptin Market Under COVID-19
9 Middle East and Africa Gliptin Market Analysis by Countries
9.1 Middle East and Africa Gliptin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Gliptin Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Gliptin Revenue by Countries (2016-2021)
9.1.3 Middle East and Africa Gliptin Market Under COVID-19
9.2 Saudi Arabia Gliptin Sales and Growth Rate (2016-2021)
9.3 UAE Gliptin Sales and Growth Rate (2016-2021)
9.4 Egypt Gliptin Sales and Growth Rate (2016-2021)
9.5 Nigeria Gliptin Sales and Growth Rate (2016-2021)
9.6 South Africa Gliptin Sales and Growth Rate (2016-2021)
10 South America Gliptin Market Analysis by Countries
10.1 South America Gliptin Sales, Revenue and Market Share by Countries
10.1.1 South America Gliptin Sales by Countries (2016-2021)
10.1.2 South America Gliptin Revenue by Countries (2016-2021)
10.1.3 South America Gliptin Market Under COVID-19
10.2 Brazil Gliptin Sales and Growth Rate (2016-2021)
10.2.1 Brazil Gliptin Market Under COVID-19
10.3 Argentina Gliptin Sales and Growth Rate (2016-2021)
10.4 Columbia Gliptin Sales and Growth Rate (2016-2021)
10.5 Chile Gliptin Sales and Growth Rate (2016-2021)
11 Global Gliptin Market Segment by Types
11.1 Global Gliptin Sales, Revenue and Market Share by Types (2016-2021)
11.1.1 Global Gliptin Sales and Market Share by Types (2016-2021)
11.1.2 Global Gliptin Revenue and Market Share by Types (2016-2021)
11.2 Sitagliptin (Januvia) Sales and Price (2016-2021)
11.3 Vildagliptin (Galvus) Sales and Price (2016-2021)
11.4 Saxagliptin (Onglyza) Sales and Price (2016-2021)
11.5 Linagliptin (Tradjenta) Sales and Price (2016-2021)
11.6 Alogliptin (Vipidia/Nesina) Sales and Price (2016-2021)
11.7 Other Types Sales and Price (2016-2021)
12 Global Gliptin Market Segment by Applications
12.1 Global Gliptin Sales, Revenue and Market Share by Applications (2016-2021)
12.1.1 Global Gliptin Sales and Market Share by Applications (2016-2021)
12.1.2 Global Gliptin Revenue and Market Share by Applications (2016-2021)
12.2 Type 2 Diabetes Sales, Revenue and Growth Rate (2016-2021)
12.3 OtherDiseases Sales, Revenue and Growth Rate (2016-2021)
13 Gliptin Market Forecast by Regions (2021-2027)
13.1 Global Gliptin Sales, Revenue and Growth Rate (2021-2027)
13.2 Gliptin Market Forecast by Regions (2021-2027)
13.2.1 North America Gliptin Market Forecast (2021-2027)
13.2.2 Europe Gliptin Market Forecast (2021-2027)
13.2.3 Asia-Pacific Gliptin Market Forecast (2021-2027)
13.2.4 Middle East and Africa Gliptin Market Forecast (2021-2027)
13.2.5 South America Gliptin Market Forecast (2021-2027)
13.3 Gliptin Market Forecast by Types (2021-2027)
13.4 Gliptin Market Forecast by Applications (2021-2027)
13.5 Gliptin Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Gliptin Market Size Growth Rate by Type (2021-2027)
Figure Global Gliptin Market Share by Type in 2020 & 2026
Figure Sitagliptin (Januvia) Features
Figure Vildagliptin (Galvus) Features
Figure Saxagliptin (Onglyza) Features
Figure Linagliptin (Tradjenta) Features
Figure Alogliptin (Vipidia/Nesina) Features
Figure Other Types Features
Table Global Gliptin Market Size Growth by Application (2021-2027)
Figure Global Gliptin Market Share by Application in 2020 & 2026
Figure Type 2 Diabetes Description
Figure OtherDiseases Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Gliptin Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Gliptin Market Size and Growth Rate 2016-2027
Table Industry News
Table Industry Policies
Figure Value Chain Status of Gliptin
Figure Production Process of Gliptin
Figure Manufacturing Cost Structure of Gliptin
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Eli Lilly Profile
Table Eli Lilly Production, Value, Price, Gross Margin 2016-2021
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2016-2021
Table LGM Pharma Profile
Table LGM Pharma Production, Value, Price, Gross Margin 2016-2021
Table Boehringer Ingelheim Pharmaceuticals, Inc. Profile
Table Boehringer Ingelheim Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2016-2021
Table Novartis International AG Profile
Table Novartis International AG Production, Value, Price, Gross Margin 2016-2021
Table AstraZeneca Profile
Table AstraZeneca Production, Value, Price, Gross Margin 2016-2021
Figure Global Gliptin Sales and Growth Rate (2016-2021)
Figure Global Gliptin Revenue ($) and Growth (2016-2021)
Table Global Gliptin Sales by Regions (2016-2021)
Table Global Gliptin Sales Market Share by Regions (2016-2021)
Table Global Gliptin Revenue ($) by Regions (2016-2021)
Table Global Gliptin Revenue Market Share by Regions (2016-2021)
Table Global Gliptin Revenue Market Share by Regions in 2016
Table Global Gliptin Revenue Market Share by Regions in 2020
Figure North America Gliptin Sales and Growth Rate (2016-2021)
Figure Europe Gliptin Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Gliptin Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Gliptin Sales and Growth Rate (2016-2021)
Figure South America Gliptin Sales and Growth Rate (2016-2021)
Figure North America Gliptin Revenue ($) and Growth (2016-2021)
Table North America Gliptin Sales by Countries (2016-2021)
Table North America Gliptin Sales Market Share by Countries (2016-2021)
Figure North America Gliptin Sales Market Share by Countries in 2016
Figure United States Gliptin Sales and Growth Rate (2016-2021)
Figure Canada Gliptin Sales and Growth Rate (2016-2021)
Figure Mexico Gliptin Sales and Growth (2016-2021)
Figure Europe Gliptin Revenue ($) Growth (2016-2021)
Table Europe Gliptin Sales by Countries (2016-2021)
Table Europe Gliptin Sales Market Share by Countries (2016-2021)
Figure Germany Gliptin Sales and Growth Rate (2016-2021)
Figure UK Gliptin Sales and Growth Rate (2016-2021)
Figure France Gliptin Sales and Growth Rate (2016-2021)
Figure Italy Gliptin Sales and Growth Rate (2016-2021)
Figure Spain Gliptin Sales and Growth Rate (2016-2021)
Figure Russia Gliptin Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Gliptin Revenue ($) and Growth (2016-2021)
Table Asia-Pacific Gliptin Sales by Countries (2016-2021)
Table Asia-Pacific Gliptin Sales Market Share by Countries (2016-2021)
Figure China Gliptin Sales and Growth Rate (2016-2021)
Figure Japan Gliptin Sales and Growth Rate (2016-2021)
Figure South Korea Gliptin Sales and Growth Rate (2016-2021)
Figure Australia Gliptin Sales and Growth Rate (2016-2021)
Figure India Gliptin Sales and Growth Rate (2016-2021)
Figure Southeast Asia Gliptin Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Gliptin Revenue ($) and Growth (2016-2021)
Table Middle East and Africa Gliptin Sales by Countries (2016-2021)
Table Middle East and Africa Gliptin Sales Market Share by Countries (2016-2021)
Figure Saudi Arabia Gliptin Sales and Growth Rate (2016-2021)
Figure UAE Gliptin Sales and Growth Rate (2016-2021)
Figure Egypt Gliptin Sales and Growth Rate (2016-2021)
Figure Nigeria Gliptin Sales and Growth Rate (2016-2021)
Figure South Africa Gliptin Sales and Growth Rate (2016-2021)
Figure South America Gliptin Revenue ($) and Growth (2016-2021)
Figure Brazil Gliptin Sales and Growth Rate (2016-2021)
Figure Argentina Gliptin Sales and Growth Rate (2016-2021)
Figure Columbia Gliptin Sales and Growth Rate (2016-2021)
Figure Chile Gliptin Sales and Growth Rate (2016-2021)
Table Global Gliptin Sales by Types (2016-2021)
Table Global Gliptin Revenue ($) by Types (2016-2021)
Figure Global Sitagliptin (Januvia) Sales and Growth Rate (2016-2021)
Figure Global Sitagliptin (Januvia) Price (2016-2021)
Figure Global Vildagliptin (Galvus) Sales and Growth Rate (2016-2021)
Figure Global Vildagliptin (Galvus) Price (2016-2021)
Figure Global Saxagliptin (Onglyza) Sales and Growth Rate (2016-2021)
Figure Global Saxagliptin (Onglyza) Price (2016-2021)
Figure Global Linagliptin (Tradjenta) Sales and Growth Rate (2016-2021)
Figure Global Linagliptin (Tradjenta) Price (2016-2021)
Figure Global Alogliptin (Vipidia/Nesina) Sales and Growth Rate (2016-2021)
Figure Global Alogliptin (Vipidia/Nesina) Price (2016-2021)
Figure Global Other Types Sales and Growth Rate (2016-2021)
Figure Global Other Types Price (2016-2021)
Table Global Gliptin Sales by Applications (2016-2021)
Table Global Gliptin Sales Share by Applications (2016-2021)
Figure Global Type 2 Diabetes Sales and Growth Rate (2016-2021)
Figure Global Type 2 Diabetes Revenue and Growth Rate (2016-2021)
Figure Global OtherDiseases Sales and Growth Rate (2016-2021)
Figure Global OtherDiseases Revenue and Growth Rate (2016-2021)
Figure Global Gliptin Sales and Growth Rate (2021-2027)
Figure Global Gliptin Revenue ($) and Growth Rate (2021-2027)
Table Global Gliptin Sales Forecast by Regions (2021-2027)
Table Global Gliptin Revenue Forecast by Regions (2021-2027)
Figure North America Gliptin Sales Forecast (2021-2027)
Figure North America Gliptin Revenue Forecast (2021-2027)
Figure Europe Gliptin Sales Forecast (2021-2027)
Figure Europe Gliptin Revenue Forecast (2021-2027)
Figure Asia-Pacific Gliptin Sales Forecast (2021-2027)
Figure Asia-Pacific Gliptin Revenue Forecast (2021-2027)
Figure Middle East and Africa Gliptin Sales Forecast (2021-2027)
Figure Middle East and Africa Gliptin Revenue Forecast (2021-2027)
Figure South America Gliptin Sales Forecast (2021-2027)
Figure South America Gliptin Revenue Forecast (2021-2027)
Table Global Gliptin Sales Forecast by Types (2021-2027)
Table Global Gliptin Sales Market Share Forecast by Types (2021-2027)
Table Global Gliptin Revenue Market Share Forecast by Types (2021-2027)
Table Global Gliptin Sales Market Share Forecast by Applications (2021-2027)
Table Global Gliptin Revenue Forecast by Applications (2021-2027)
Table Global Gliptin Revenue Market Share Forecast by Applications (2021-2027)
Research Methodology:
Gliptin Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|